<DOC>
	<DOC>NCT02608632</DOC>
	<brief_summary>To increase the number of responders using HFS-guided renal artery denervation (RDN) in patients with resistant and moderate resistant hypertension</brief_summary>
	<brief_title>HFS-guided Renal Ablation for Improving Outcome of Renal Denervation Procedure</brief_title>
	<detailed_description />
	<criteria>Officebased systolic blood pressure of ≥140/90 mm Hg and &lt;160/100 mm Hg (moderate resistant hypertension) or ≥160/100 mm Hg (severe resistant hypertension), despite treatment with 3 antihypertensive drugs (including a diuretic). A glomerular filtration rate ≥45 mL/min/1⋅73 m2, with modification of diet using a renal disease formula. Secondary causes of hypertension Severe renal artery stenosis or dual renal arteries Congestive heart failure Left ventricular ejection fraction &lt;35% Previous renal artery stenting or angioplasty Type 1 diabetes mellitus</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Renal denervation</keyword>
	<keyword>Ablation</keyword>
</DOC>